LMNA and cardiomyopathy: Specifically, in vivo research on LMNA mutations is further hindered by the lack of an optimal animal model for LMNA cardiomyopathies and also that the clinical phenotypes resulting from LMNA mutations, also known as laminopathies, are highly variable due to the involvement of other organ systems and accelerated aging syndrome (progeria) [7].